logo
Congratulations to Merry Jiang of JHU, the 2025 CAHME/Olin Oedekoven Scholarship Recipient for Most Improved Student 

Congratulations to Merry Jiang of JHU, the 2025 CAHME/Olin Oedekoven Scholarship Recipient for Most Improved Student 

'These students are integral to driving meaningful change in the field and support CAHME's mission to advance the quality of healthcare management education.'— Dr. Anthony Stanowski, DHA, FACHE, President and CEO of CAHME
SPRING HOUSE , PA, UNITED STATES, April 30, 2025 / EINPresswire.com / -- Merry Jiang, a Master of Healthcare Administration (MHA) Candidate at Johns Hopkins University, has been named the 2025 recipient of the CAHME /Olin Oedekoven Scholarship for Most Improved Student .
CAHME scholarships recognize students enrolled in CAHME accredited programs who demonstrate exceptional potential to innovate and drive meaningful change in healthcare. This award was presented during the 10th Annual CAHME Awards Ceremony at the American College of Healthcare Executives (ACHE) Congress on Healthcare Leadership on March 23, 2025.
'Merry was chosen for her leadership and motivation to inspire true change in healthcare. With a clear focus on enhancing patient experience and improving safety and quality of care, she is dedicated to shaping a better healthcare system. As a mentor, Merry actively supports and guides her peers, fostering a collaborative and empowering environment. Her actions reflect a deep commitment to transformative change and a passion for advancing the future of healthcare,' said Kayla Vos, Chief Operating Officer, Peregrine Global Services.
'I am honored to have nominated Merry Jiang for the CAHME/Olin Oedekoven Scholarship for Most Improved Student. Her experiences have shaped her into a dynamic force within the field, with a deep understanding of both the challenges and opportunities in healthcare. Merry currently serves as the Secretary of the MHA Student Association and was chosen as the Administrative Resident in the Integration Office at the University of Maryland Medical System (UMMS). In this role, she works closely with the CEO and C-suite leadership, contributing to strategic initiatives that influence all eight hospitals and 43 shared business units within the system,' said Dr. Mark Bittle, DrPH, MBA, FACHE, MHA Program Director at Johns Hopkins University.
'CAHME scholarship recipients are a testament to the dedication of students who represent the future of healthcare leadership. These awards honor individuals who not only excel academically but also show an unwavering commitment to driving meaningful change in healthcare through innovation and advocacy,' said Anthony Stanowski, DHA, FACHE, President and CEO of CAHME.
'I am truly honored to have been chosen for the CAHME/Olin Oedekoven Scholarship for Most Improved Student. This recognition is not just a personal achievement, but a testament to the guidance, support, and inspiration I've received along the way. Winning this award strengthens my resolve to continue working toward improving healthcare systems and optimizing operational efficiency, as I've done through my project management and data-driven initiatives as an Administrative Resident at UMMS. It provides me with the motivation and resources to keep pushing forward in my studies and future career,' said Merry Jiang, MHA Candidate at Johns Hopkins University and 2025 CAHME Award Recipient.
About CAHME
Since 1968, the Commission on Accreditation of Healthcare Management Education (CAHME) has advanced the quality of healthcare management education globally. CAHME accredits 157 programs in over 40 states, territories, and provinces throughout the United States, Canada, and other countries. CAHME Accreditation is the benchmark for students and employers alike that ensures that students are well prepared to lead in healthcare management.
About the CAHME/Olin Oedekoven Most Improved Student Scholarship
The CAHME/Olin Oedekoven Most Improved Student Scholarship is named for Olin Oedekoven, who founded Peregrine Global Services. Peregrine emerged as a global leader and thought-partner in higher education services, providing online assessment and instructional solutions to more than 500 higher education institutions worldwide. Olin had strong leadership, an entrepreneurial spirit, and a deep-seated commitment to making a meaningful difference.
About the MHA Program at The Johns Hopkins Bloomberg School of Public Health
The Johns Hopkins Bloomberg School of Public Health's Master's in Health Administration (MHA) program is uniquely designed for future health care executives early in their careers. The accelerated curriculum includes one year of full-time academic coursework followed by a full-time, 11-month compensated administrative residency in one of many Hopkins affiliate or partner institutions across the country.
MHA graduates leave the program with high-level, hands-on experience, a professional network, and the analytical, technical, and management skills required to lead in hospitals and health systems, the health insurance industry, and consulting firms.
Megan Vohden
CAHME
+1 301-298-1820 ext. 704
email us here
Legal Disclaimer:
EIN Presswire provides this news content 'as is' without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

University of Maryland Medical System files $15 million lawsuit over denied health service claims
University of Maryland Medical System files $15 million lawsuit over denied health service claims

CBS News

time17 hours ago

  • CBS News

University of Maryland Medical System files $15 million lawsuit over denied health service claims

The University of Maryland Medical System has filed a lawsuit against Physicians Care MCO, accusing the company of improperly denying $15 million in claims for health services. Physicians Care MCO is one of four companies that manages Medicare claims for the state. The UMMS says the company denied claims to 15,000 lower-income patients who use Medicaid. This group of patients includes individuals who were infected with COVID-19, and premature babies treated in neonatal intensive care units, according to the lawsuit. According to the lawsuit, Physicians Care MCO denied claims in a way that violated federal and state laws, as well as its contract with the health system. The UMMS said the company engaged in a "longstanding, ongoing, deliberate, and systematic practice of denying timely and complete payment." Lawsuit details claims of wrongful denial of coverage The lawsuit details multiple examples of what the UMMC says was unlawful denial of coverage. According to the lawsuit, MPC decided that a patient no longer needed to stay in the hospital, despite having recently survived cardiac arrest and a gunshot wound, because their level of pain was deemed too low to warrant continued care. In another case, the suit alleges that MPC denied coverage to a patient with multiple active medical conditions including a recent stroke, HIV, COVID-19, and sepsis - while that patient was still fighting to stabilize. In one example the UMMC said the company declined coverage to a premature infant that was exposed to fentanyl and cocaine in utero. The infant was diagnosed with extreme respiratory distress, recurrent apnea, severe feeding intolerance, and numerous other comorbidities associated with extreme prematurity, according to the lawsuit. "These denials were not just inappropriate—they were cruel. They demonstrate that MPC's corporate profit motives override the medical needs of the sickest and smallest patients in the State," the UMMS wrote. The Baltimore Banner reached out to Physicians Care MCO, but a response has not yet been received.

‘Forever chemicals' exposure before birth raises the risk of high blood pressure in teenage years
‘Forever chemicals' exposure before birth raises the risk of high blood pressure in teenage years

Yahoo

time4 days ago

  • Yahoo

‘Forever chemicals' exposure before birth raises the risk of high blood pressure in teenage years

'Forever chemicals' may be taking their toll on our health before we are even born, new research suggests. Per- and polyfluoroalkyl substances, or PFAS, are a group of chemicals used in everyday products like food packaging and non-stick cookware. They're known as 'forever chemicals' because they don't degrade easily and can build up in the environment – and in our bodies. Scientists have detected PFAS in people's blood, breast milk, semen, livers, and even brains. They suspect these chemicals harm human health, with studies linking them to higher cholesterol, some cancers, and fertility problems, among other issues. The new research adds another complication to that list: high blood pressure during adolescence. Related Forever chemicals: Brussels' mission to clean up Europe's water The analysis followed more than 1,000 children in the US. It used maternal plasma collected shortly after they were born to identify their level of prenatal PFAS exposure, and matched it to doctors' records up until their 18th birthdays. Prenatal exposure to PFAS was linked to a higher risk of developing high blood pressure later in childhood, particularly in the teenage years, according to the study published in the Journal of the American Heart Association. The findings indicate that 'these forever chemicals can have long-lasting and potentially harmful effects that may only become apparent years after birth,' Zeyu Li, the study's lead author and a researcher at Johns Hopkins University in the US, said in a statement. The risk of elevated blood pressure was even higher for boys and Black children with higher PFAS levels at birth, the study found. Related How 'dangerous chemicals' detected in products in the EU could be impacting your health In a surprise to researchers, a handful of forever chemicals were actually linked to lower diastolic, or bottom number, blood pressure in early childhood, though that changed when they entered their teenage years. Evidence on the health effects of PFAS has been mixed so far. While researchers believe these chemicals pose risks, it's difficult to pinpoint their exact impact because there are thousands of PFAS that could all interact in different ways, and because people's exposure changes over time. Even so, Li said the latest study underscores the need for researchers to track people's health and their PFAS levels over a long period of time, from early childhood to adolescence and beyond. Related How to avoid 'forever chemicals': 5 items you should stop using to minimise exposure to PFAS Meanwhile, Mingyu Zhang, the study's senior author and an assistant professor at Harvard Medical School, said stronger environmental protections are needed to protect people from PFAS, given they are so ubiquitous that people cannot meaningfully limit their exposure on their own. That could include phasing out forever chemicals from consumer products and in industrial settings, he said, as well as better surveillance and limits on PFAS in water systems. 'This is not something individuals can solve on their own,' Zhang said.

Prenatal exposure to ‘forever chemicals' may raise blood pressure during teen years: Study
Prenatal exposure to ‘forever chemicals' may raise blood pressure during teen years: Study

Yahoo

time4 days ago

  • Yahoo

Prenatal exposure to ‘forever chemicals' may raise blood pressure during teen years: Study

Humans exposed to toxic 'forever chemicals' before birth may exhibit higher blood pressure during their teenage years, a new study has found. This connection was particularly pronounced in boys and in children born to non-Hispanic Black mothers, scientists observed in the study, published Thursday in the Journal of the American Heart Association. While previous research has shown these synthetic compounds may affect a rapidly developing fetus, the new study was able to investigate impacts on blood pressure from early childhood through adolescence. 'This suggests these forever chemicals can have long-lasting and potentially harmful effects that may only become apparent years after birth,' lead author Zeyu Li, a graduate student researcher in public health at Johns Hopkins University, said in a statement. Forever chemicals, or per- and polyfluoroalkyl substances (PFAS), have been linked to numerous illnesses, such as kidney cancer, testicular cancer, thyroid disease, cardiovascular conditions and preeclampsia — also a blood pressure issue. Notorious for their inability to break down in the environment, PFAS are present in a wide range of household products, including cosmetics, waterproof apparel and nonstick pans, as well as in certain kinds of firefighting foams. To draw their conclusions, the study's authors tracked 1,094 children from a group called the Boston Birth Cohort over a median span of about 12 years. The researchers analyzed more than 13,000 blood pressure readings taken at routine pediatric visits from July 2001 to February 2024, grouping the results into age brackets of 3-5, 6-12 and 13-18. They then calculated age-, sex- and height-specific blood pressure percentiles, while accounting for the mother's health, delivery method, socioeconomic factors and weekly fish consumption, as fish are a known source of PFAS contamination. Among the children whose mothers had higher levels of the chemicals in blood samples collected after delivery, the scientists identified issues with three types of PFAS: PFDeA, PFNA and PFUnA. As levels of these PFAS doubled in the moms, systolic blood pressure — the top number in a reading, or the pressure in the arteries when the heart contracts — were between 1.39 percentile points and 2.78 percentile points higher in the 13- to 18-year-old age group. Under these conditions, diastolic pressure — the bottom number, or the pressure when the heart muscle relaxes between beats — surged 1.22 percentile points to 2.54 percentile points higher among members of this cohort. With the doubling of maternal PFAS blood levels, the risk of elevated blood pressure rose by 6 percent to 8 percent in boys and in children born to non-Hispanic Black mothers, according to the study. Li expressed hope that due to the study's findings, more researchers might be inspired to track such effects in children into adolescence. 'Many past studies stopped at early or mid-childhood, however, our study shows that the health effects of prenatal PFAS exposure may not appear until the teen years,' Li said. Senior author Mingyu Zhang, an assistant professor at Beth Israel Deaconess Medical Center and Harvard Medical School, stressed that reducing prenatal and childhood exposure to PFAS requires policy-level action, as well as product phaseouts and widespread water regulation. 'This is not something individuals can solve on their own,' Zhang added. Justin Zachariah, an associate professor at Baylor College of Medicine who was not involved with the study, explained that PFAS interfere with hormones and disrupt typical adolescent development. While scientists are already aware that boys and Black children are at increased risk of elevated blood pressure, exposure to these compounds may exacerbate that risk, warned Zachariah, who also chaired the American Heart Association's 2024 scientific panel on pediatric cardiology and environmental exposures. 'These chemicals last in our bodies for years, suggesting that perhaps prenatal exposure may have occurred before conception, and these chemicals may cause changes that can carry forward for generations,' Zachariah said. 'Therefore, improvements we make could echo for generations to come,' he added. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store